SCHEMBL6426124

SCHEMBL6426124

COc1cnc(-c2n[nH]cc2C)c2[nH]cc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3)c12

nearest known ligand 0.73

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 5/20 0.73
CYP2C19 P33261 6/20 0.66
CYP2D6 P10635 5/20 0.66
CYP3A4 P08684 3/20 0.66
CYP1A2 P05177 2/20 0.66
CYP2C8 P10632 1/20 0.66
CYP2B6 P20813 1/20 0.66
KCNH2 Q12809 1/20 0.66
ALDH1A1 P00352 2/20 0.40
CNR2 P34972 1/20 0.39
TSHR P16473 1/20 0.39
CKS1B P61024 1/20 0.37
SKP1 P63208 1/20 0.37
SKP2 Q13309 1/20 0.37
BTK Q06187 1/20 0.37
ABL1 P00519 1/20 0.37
BCR P11274 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6422639 0.89 CYP2C9 (0.56) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL4075885 0.88 CYP2C9 (0.73) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL1763051 0.88 CYP2C9 (0.78) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL1763629 0.87 CYP2C9 (0.74) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL1763243 0.86 CYP2C9 (0.71) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL17861491 0.86 CYP2C9 (0.82) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL1763634 0.86 CYP2C9 (0.73) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL1763462 0.86 CYP2C9 (0.73) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL1763324 0.86 CYP2C9 (0.75) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL2629254 0.86 CYP2C9 (0.70) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1549313-A1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES Bristol-Myers Squibb Company (US) 2005-07-06 EP disclosed
WO-2004014380-A1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2004-02-19 WO disclosed